Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Michl

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Gut|December 19, 2025
Hereditary chronic pancreatitis induced plasticity cooperates with mutant Kras in early pancreatic carcinogenesisTanvi Vikrant Inamdar, Ferdinand Krannich, Nico Hesselbarth, et al.
The Lancet. Gastroenterology & Hepatology|August 19, 2024
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trialKlara Dorman, Stefan Boeck, Karel Caca, et al.
BMJ Open|September 10, 2025
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)Conrad Rauber, Maria Paula Roberti, Maria Jgt Vehreschild, et al.
United European Gastroenterology Journal|December 17, 2019
Mean muscle attenuation correlates with severe acute pancreatitis unlike visceral adipose tissue and subcutaneous adipose tissueHanna Sternby, Mariella Mahle, Nicolas Linder, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO studyArndt Vogel, Stefan Kasper, Michael Bitzer, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 3, 2020
Characterization of CEL-DUP2: Complete duplication of the carboxyl ester lipase gene is unlikely to influence risk of chronic pancreatitisKarianne Fjeld, Emmanuelle Masson, Jin-Huan Lin, et al.
Zeitschrift Fur Gastroenterologie|March 9, 2022
Georg Beyer, Albrecht Hoffmeister, Patrick Michl, et al.
German Medical Science : GMS E-Journal|July 1, 2021
Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR)Petra Hoffmüller, Monika Brüggemann, Thomas Eggermann, et al.
Pain|November 20, 2025
Beyond Ammann's pain classification: multidimensional pain phenotyping and cluster analysis in chronic pancreatitisLouise Kuhlmann, Søren Schou Olesen, Ana Dugic, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 25, 2022
Colocalization analysis of pancreas eQTLs with risk loci from alcoholic and novel non-alcoholic chronic pancreatitis GWAS suggests potential disease causing mechanismsAndreas W Schmidt, Andreas Kühnapfel, Holger Kirsten, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Gut|December 19, 2025
Hereditary chronic pancreatitis induced plasticity cooperates with mutant Kras in early pancreatic carcinogenesisTanvi Vikrant Inamdar, Ferdinand Krannich, Nico Hesselbarth, et al.
The Lancet. Gastroenterology & Hepatology|August 19, 2024
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trialKlara Dorman, Stefan Boeck, Karel Caca, et al.
BMJ Open|September 10, 2025
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)Conrad Rauber, Maria Paula Roberti, Maria Jgt Vehreschild, et al.
United European Gastroenterology Journal|December 17, 2019
Mean muscle attenuation correlates with severe acute pancreatitis unlike visceral adipose tissue and subcutaneous adipose tissueHanna Sternby, Mariella Mahle, Nicolas Linder, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO studyArndt Vogel, Stefan Kasper, Michael Bitzer, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 3, 2020
Characterization of CEL-DUP2: Complete duplication of the carboxyl ester lipase gene is unlikely to influence risk of chronic pancreatitisKarianne Fjeld, Emmanuelle Masson, Jin-Huan Lin, et al.
Zeitschrift Fur Gastroenterologie|March 9, 2022
Georg Beyer, Albrecht Hoffmeister, Patrick Michl, et al.
German Medical Science : GMS E-Journal|July 1, 2021
Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR)Petra Hoffmüller, Monika Brüggemann, Thomas Eggermann, et al.
Pain|November 20, 2025
Beyond Ammann's pain classification: multidimensional pain phenotyping and cluster analysis in chronic pancreatitisLouise Kuhlmann, Søren Schou Olesen, Ana Dugic, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 25, 2022
Colocalization analysis of pancreas eQTLs with risk loci from alcoholic and novel non-alcoholic chronic pancreatitis GWAS suggests potential disease causing mechanismsAndreas W Schmidt, Andreas Kühnapfel, Holger Kirsten, et al.
Pageof 16